AXA PPP healthcare has agreed a deal with med-tech and artificial intelligence (AI) group, BioBeats, to offer its wellbeing platform and app, Hear and Now, for the insurer’s UK corporate clients.
BioBeats said Hear and Now has specifically been selected by AXA as its digital healthcare platform due to its ability to help users manage their work-related stress, wellbeing and fatigue.
BioBeats and AXA will initially offer the platform to the insurer’s large corporate customers, with their employees able to access the platform and app via their smartphone and wearable devices.
Dr. David Plans, CEO of BioBeats, said: “The way people monitor and engage in their health is changing – innovations in technology mean greater knowledge and insight is available instantly at our fingertips. Together, BioBeats and AXA want to harness this knowledge.
“The aim of our platform and app and its future developments is to help users track and improve their overall wellbeing by continuously monitoring levels of physical and mental stress in real-time. The goal is to help our users avoid chronic conditions that arise from unmanaged stress.”
Simon Miller, head of Proposition for AXA PPP healthcare, added: “AXA’s corporate wellness strategy is to change the way employers help their employees to manage their health and wellbeing. BioBeats Hear and Now app is pioneering a new era of preventive health where real-time physical and psychological data will enable us to provide individuals with unprecedented insights into and opportunities to improve and maintain their health and wellbeing.
“Employers will benefit too, with access to anonymised workforce stress data enabling them to shape more effectively their strategies for improving employee wellness, job satisfaction and performance and, in turn, better manage sickness absence, presenteeism and productivity.”
In January 2017, BioBeats published a groundbreaking paper in the Frontiers in Human Neuroscience journal entitled “The Association between Work-related Rumination and Heart Rate Variability: a Field Study.” This paper, based on BioBeats’ pilot study with one of the world’s leading financial services institutions, examined the neurophysiology of stress and rumination and was the first ever piece of research to prove the link between rumination (the process of thinking about work outside of work) and cardiovascular disease.
According to the research, the stress of constantly working – being connected to your phone, laptop, and emails, without any dedicated interventions, can be deadly as it is linked to cardiovascular disease. The study also revealed the shocking statistic that, “one in two City workers in London are more stressed at home than they are at work.”
Founded in 2013, BioBeats has developed AI algorithms and software based on evidence-based stress management to target wellbeing in the workplace.
BioBeats software identifies stress patterns using existing sensors in smartphones and/or wearable devices such as the Apple Watch, Garmin, Mio, FitBit and Microsoft Band as well as devices by Huawei and LG through BioBeats’ collaboration with Google – allowing users to understand how their body and mind respond to stress and how it affects them in their work and personal life.